Common antidepressant may help adults with long COVID: study
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
#Canada #Health #Fluvoxamine #longcovid
https://globalnews.ca/news/11752953/common-antidepressant-may-help-adults-long-covid/